Benzamide, N-[2-[(3S)-3-[[4-hydroxy-4-[5-(2-pyrimidinyl)-2-pyridinyl]cyclohexyl]amino]-1-pyrrolidinyl]-2-oxoethyl]-3-(trifluoromethyl)-, 98%, 1g

Coladores de células Flowmi, 40 µm 50 uds.

(R)-4-BENZYL-2-(QUINOLIN-2-YL)-4,5-DIHYDROOXAZOLE, 95%, 100mg

1-(2,4-Dihydroxyphenyl)-2-phenylethanone, 95.0%, 25g

5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-ol, 5g

4,5-Difluoro-2-hydroxybenzoic acid, 95.0%, 250mg

(3S,6S,9S,12S,15S)-METHYL 3-BENZYL-1-(4-(TERT-BUTYL)PHENYL)-12-(4-(DIETHYLAMINO)BUTYL)-15-(HYDROXYMETHYL)-9-ISOBUTYL-6-METHYL-1,4,7,10,13-PENTAOXO-2,5,8,11,14-PENTAAZAHEXADECAN-16-OATE, 95%, 1mg

3-Methyl-6-(4-methyl-3-nitrophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-amine, 97%, 100mg

Tetramethylene sulfoxide, 95.0%, 25g

1-(2-Bromo-3-fluorophenyl)ethan-1-one, 97%, 100mg

1-Methyl-6-oxo-1,6-dihydro-pyridazine-3-carboxylic acid, 95.0%, 5g

2-(3,4-Dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

5,5-Dimethyl-morpholin-3-one, 98.0%, 5g